A study in humans identified the miR-4632-5p as a biomarker for recurrent myocardial infarction risk, finding it was downregulated in whole blood of patients with recurrent MI after percutaneous coronary intervention, with this differential expression remaining significant after false-discovery rate correction, though it was not significantly different in plasma samples [Onuoha et al. DOI:10.1111/cts.13307].